Avid Bioservices Inc (CDMO)

[skweze]

Can they sit on info like that? Aren't the findings on the data a material event requiring disclosure because of the "discrepancy" PR in September?

I spoke with Chris Keenan today. I pointed out that the Corporate Fact Sheet on the website indicates the Internal Review of 2nd-line NSCLC data will be completed by middle of the current calendar quarter, i.e. Feb 15, which is two weeks from tomorrow. I asked if this time line was still a good projection of when the PR would be released with final data from the 2nd-line lung trial … and he said “YES.”

He noted, however, that the pending PR may include top-line data only and that the PR may say that some of the data is being reserved for presentation at ASCO.